Advanced search
Publication Cover
Journal of Asthma Volume 60, 2023 - Issue 4
Submit an article Journal homepage
204
Views
1
CrossRef citations to date
0
Altmetric
Articles

The assessment of effectiveness, tolerance, and patient satisfaction with the use of a new fixed-dose combination product, containing salmeterol and fluticasone propionate, Salflumix Easyhaler® in the treatment of asthma in the daily clinical practice

Zbigniew Donieca Department of Pneumonology, Institute of Tuberculosis and Lung Diseases, Rabka-Zdrój, PolandORCID Iconhttps://orcid.org/0000-0003-3896-1053View further author information
, MDORCID Icon,
Magdalena Olszanecka-Glinianowiczb Health Promotion and Obesity Management Unit, Department of Pathophysiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, PolandORCID Iconhttps://orcid.org/0000-0001-5632-5590View further author information
, MDORCID Icon,
Piotr Hantulikc Orion Pharma Poland Co. Ltd, Warszawa, PolandORCID Iconhttps://orcid.org/0000-0001-5088-5204View further author information
, MDORCID Icon,
Agnieszka Almgren-Rachtand Euromedic Medical Centre, Katowice, PolandORCID Iconhttps://orcid.org/0000-0002-6766-8123View further author information
, PhDORCID Icon &
Jerzy Chudeke Pathophysiology Unit, Department of Internal Diseases and Oncological Chemotherapy, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, PolandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6367-7794View further author information
, MDORCID Icon
Pages 754-760 | Received 09 Mar 2022, Accepted 18 Jun 2022, Published online: 30 Jun 2022

References

  • O’Byrne PM, Pedersen S, Schatz M, Thoren A, Ekholm E, Carlsson LG, Busse WW. The poorly explored impact of uncontrolled asthma. Chest 2013;143(2):511–523. doi:10.1378/chest.12-0412.
  • Wilson SR, Rand CS, Cabana MD, Foggs MB, Halterman JS, Olson L, Vollmer WM, Wright RJ, Taggart V. Asthma outcomes: quality of life. J Allergy Clin Immunol 2012;129(3 Suppl):S88– S123. doi:10.1016/j.jaci.2011.12.988.
  • Brożek GM, Nowak M, Pierzchała W, Zejda JE. Profile of adults suffering from asthma in Poland–results of PulmoScreen study. Pneumonol Alergol Pol 2012;80(5):402–411. doi:10.5603/ARM.27554.
  • Kirjavainen M, Mattila L, Vahteristo M, Korhonen J, Lähelmä S. Pharmacokinetics of salmeterol and fluticasone propionate delivered in combination via EASYHALER® and Diskus dry powder inhalers in healthy subjects. J Aerosol Med Pulm Drug Deliv 2018;31(5):290–297. doi:10.1089/jamp.2017.1437.
  • Seretide Diskus - Summary of product characteristics. https://gskpro.com.
  • Derom EY, Pauwels RA, Van der Straeten ME. The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours. J Allergy Clin Immunol 1992;89(4):811–815. doi:10.1016/0091-6749(92)90435-5.
  • D’Urzo AD. Long-acting beta 2-agonists. Role in primary care asthma treatment. Can Fam Physician. 1997;43:1773–1777.
  • Johnson M. The anti-inflammatory profile of fluticasone propionate. Allergy. 1995;50(23 Suppl):11–14. doi:10.1111/j.1398-9995.1995.tb02735.x.
  • Salflumix Easyhaler - Summary of product characteristics. https://docetp.mpa.se/LMF/Salflumix%20Easyhaler%20inhalation%20powder%20SmPC%20ENG_09001be681e50afa.pdf.
  • Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004;113(1):59–65. doi:10.1016/j.jaci.2003.09.008.
  • Campbell JL, Kiebert GM, Partridge MR. Development of the satisfaction with inhaled asthma treatment questionnaire. Eur Respir J 2003;22(1):127–134. doi:10.1183/09031936.03.00097503.
  • Dońka K, Czarnocki KJ, Emeryk A. Validation of the Polish version of satisfaction with Asthma Treatment Questionnaire (SATQ). Postepy Dermatol Alergol 2017;34(1):77–81. doi:10.5114/ada.2017.65625.
  • Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen SE. GOAL Investigators Group. Can guideline-defined asthma control be achieved? The gaining optimal asthma control study. Am J Respir Crit Care Med 2004;170(8):836–844. doi:10.1164/rccm.200401-033OC.
  • Bateman ED, Busse W, Pedersen SE, Bousquet J, Huang S, Zhou X, Gul N, Hollis S, Gibbs M. Global Initiative for Asthma 2016-derived asthma control with fluticasone propionate and salmeterol: A Gaining Optimal Asthma Control (GOAL) study reanalysis. Ann Allergy Asthma Immunol 2019;123(1):57–63.e2. doi:10.1016/j.anai.2019.04.018.
  • Venkitakrishnan R, Thomas PK, Bansal A, Ghosh I, Augustine J, Divya R, Cleetus M. Fluticasone/formoterol compared with other ICS/LABAs in asthma: a systematic review. J Asthma 2022;59(6):1221–1230 doi:10.1080/02770903.2021.1900864.
  • Ismaila A, Corriveau D, Vaillancourt J, Parsons D, Stanford R, Su Z, Sampalis JS. Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients. Curr Med Res Opin 2014;30(7):1417–1425. doi:10.1185/03007995.2014.908827.
  • Global Initiative for Asthma. Global strategy for asthma management and prevention, 2021. Available from: www.ginasthma.org.
  • Lavorini F, Chudek J, Gálffy G, Pallarés-Sanmartin A, Pelkonen AS, Rytilä P, Syk J, Szilasi M, Tamási L, Xanthopoulos A, et al. Switching to the Dry-Powder Inhaler Easyhaler®: a narrative review of the evidence. Pulm Ther 2021;7(2):409–427. doi:10.1007/s41030-021-00174-5.
  • Palander A, Mattila T, Karhu M, Muttonen E. In vitro comparison of three salbutamol-containing multidose dry powder inhalers: Buventol Easyhaler®, Inspiryl Turbuhaler® and Ventoline Diskus®. Clin Drug Invest 2000;20(1):25–33. doi:10.2165/00044011-200020010-00004.
  • Tashkin DP, Ohar JA, Koltun A, Allan R, Ward JK. The role of ICS/LABA fixed-dose combinations in the treatment of asthma and COPD: Bioequivalence of a generic fluticasone propionate-salmeterol device. Pulm Med 2021;2021:8881895. doi:10.1155/2021/8881895.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.